supercat
Colonel
Leland Miller: China might cure cancer - but at what cost? This is one of the people who give "advice" on China's economy. You can't make the sh*t up.
America’s national security will only stop being at risk when the entire world is bowing down and worshipping US flags whilst holding US dollars as offerings to the gods of democracy.Leland Miller: China might cure cancer - but at what cost? This is one of the people who give "advice" on China's economy. You can't make the sh*t up.
Canada is definetly next after Trump is done with Greenland especially after the who Carney and Xi meeting.America’s national security will only stop being at risk when the entire world is bowing down and worshipping US flags whilst holding US dollars as offerings to the gods of democracy.

Leland Miller: China might cure cancer - but at what cost? This is one of the people who give "advice" on China's economy. You can't make the sh*t up.
I apologize to Jordan Schneider for all the times I’ve memed him. As for Leland Miller — there are plenty of trees that need planting in the Gobi Desert and the last time I checked they ain’t planing themselves!!!!
what is korean birth numbers?
I’ve been saying it long enough if China discovered the cure to cancer, the West would be working to undermine it. Why? How will they get to charge the millions of dollars for each person that wants it? Why does the West want to prevent China from innovating and inventing anything first? It’s because they won’t be making all the money from it. That’s their excuse to claim China will do that instead. Who says there will be only one way to do it? That’s there frame of thought because that’s how they see how they’ll control and make all the money from it. Even they talk about violating China’s patents so what are they worried about China discovering anything first then? It’s because they are only looking at how much money they will make and they will not be making all of it if there are alternatives out there. If they charge more, no one will be paying for theirs. Right now the West is alarmed because they can’t compete with China on price. And who thinks it will be China gouging everyone…? They are the antagonists of the world and they know it. That’s why they want and need 100% control of everything.
I mentioned before this is what the West does that the Chinese don’t to their own detriment. They will speak for you to tell everyone what you’re thinking to turn everyone against you. This is what the Chinese should be doing to them and you don’t need to lie about it like they do. The majority is going to believe what I said above is the truth because that’s been the West’s modus operandi. With everything in the West going up in price and debate over affordability and the rich getting richer, how can you not believe that’s what they do? That’s why the Chinese should say it out loud instead of saying nothing doing nothing. That’s how they like it because they get to tell what the Chinese are thinking.
I see the problem here. The Europeans see these measures as a weapon China is striking them with rather than the way they should see it, which is a feral child finally being disciplined by a put-upon parent.
Europe whining about how China gave the West a taste of its own medicine… a taste of how they control others. The difference is the West had to colonize and steal other people’s resources in order to deny to gain leverage. As they complain about China today, China outbids them to buy the resources they need from around the world meaning China is paying the world what the West never did.
“When [we] do the math, shall we reduce the US price to France’s level or stop supplying France? We [will] stop supplying France,” Pfizer chief executive Albert Bourla
US drugmakers threaten to withhold products from Europe over prices
US pharmaceutical companies are stepping up their campaign for higher drug prices in Europe, in some cases threatening to withhold new medicine if European lawmakers refuse.
Pfizer chief executive Albert Bourla, the first pharmaceutical boss to announce a pricing agreement with US President Donald Trump last year, said the deal forced Pfizer to increase prices abroad.
“When [we] do the math, shall we reduce the US price to France’s level or stop supplying France? We [will] stop supplying France,” Bourla told reporters at the annual JPMorgan healthcare conference this week.
“So they will stay without new medicines. The system will force us not to be able to accept the lower prices.”
Other pharm executives said at the conference that they were quietly considering withholding or delaying drug launches in Europe.
Trump last year demanded drugmakers slash prices in the US or face tariffs. As of this month, 16 global drug companies — from AstraZeneca to Roche’s Genentech — have agreed to lower US drug prices. These voluntary agreements with the White House require companies to benchmark certain drugs in the US at prices in other developed countries ranging from Canada to Europe and Japan.
Trump on Friday hailed the deals as cudgels that forced Europe to increase prices. “So we go from a horrible situation on prescription drugs to the lowest price anywhere in the world,” he said.
With their deals with Trump finalised, pharmaceutical executives are raising pressure on Europe and other countries to increase prices and balance potential revenue losses in the US.
Last year, Bristol Myers Squibb threatened to halt the launchof its popular schizophrenia drug in the UK if it did not increase prices. In December, the UK promised to increase drug prices in a deal with the US.
In an interview with the FT this week, BMS’s chief commercialisation officer Adam Lenkowsky, said the UK deal did not go far enough.
“It is a positive step forward. I still think there is a long way to go.”
Daniel O’Day, chief executive of Gilead, said his company’s pricing deal with Trump “really gives us an opportunity to reset” pricing in the rest of the world.
Historically, European countries with government healthcare systems have had the power to strong-arm pharmaceutical companies into paying low prices. By contrast, the US has private and public healthcare providers that do not negotiate together for drug prices.
As the pharmaceutical companies called for higher prices, Germany’s largest public health insurance provider, Techniker Krankenkasse, said that drug prices were already too high.
“We in Germany are clearly paying too much,” said Jens Baas, chief executive of TK.
“The [German] legislature must act and urgently implement measures to reduce spending, especially in the area of patented drugs.”
Higher drug prices were unlikely to stimulate economies in Germany or Europe, Baas said. “They only increase the profit margins for pharmaceutical companies and burden those paying into the statutory health insurance system.”
TK declined to comment about the pharmaceutical executives’ statements on drug prices.
The tensions were likely to lead to delayed drug launches in Europe, analysts said.
Already, drugs launched in Europe about a year after they did in the US, said Will Humphrey, a vice-president at Capstone, a healthcare policy and consulting firm.
“All of this reminds me of the way Trump has handled Nato,” he said, referring to the US pressure campaign to force its allies to spend more on defence.
“These European nations do not have significant budget surpluses they can use to increase expenditures on drug pricing immediately. They are going to have to find a way to accommodate some of these priorities from the Trump administration or risk these drugmakers delaying their launches.”